59 / 100

Prof. Gaiqing Wang | Neurodegeneration Disease | Research and Development Excellence Award

Prof. Gaiqing Wang, Sanya Central Hospital (The Third People’s Hospital of Hainan Province), China

Prof. Gaiqing Wang is a distinguished neurologist affiliated with Sanya Central Hospital, Hainan Province, specializing in cerebrovascular diseases. Holding a Ph.D. from Central South University, he focuses on cerebral small vessel disease and endogenous waste clearance in the brain. With over 70 publications, including 27 SCI-indexed papers, Prof. Wang investigates mechanisms of intracerebral hemorrhage and neurodegenerative disorders. He leads numerous research projects funded by national and provincial bodies, exploring innovative therapeutic approaches. His contributions extend to consultancy, industry projects, and authoring books and patents. A member of prestigious professional societies, his work bridges neuroscience research with clinical applications šŸ§ šŸ”¬.

Publication profile

Orcid

Academic and Professional Background šŸŽ“

Gaiqing Wang, currently serving as a Professor at Sanya Central Hospital, earned a Ph.D. in Neurology from Central South University in 2006. Specializing in cerebral small vessel disease and brain waste clearance mechanisms, Wang has authored over 70 papers and secured funding for 13 research projects. His impactful contributions include elucidating the role of microglia in hematoma clearance post-intracerebral hemorrhage and exploring circadian regulation of brain clearance systems. Wang’s academic prowess is underscored by leadership in consultancy projects and publication of several books and patents, consolidating his standing as a distinguished figure in neurological research.

Research Focus

Gaiqing Wang primarily focuses on neuroinflammation and neuroprotection in various neurological disorders, prominently in conditions like Alzheimer’s disease, intracerebral hemorrhage, and subarachnoid hemorrhage. His research explores mechanisms involving oxidative stress, microglial activation, and therapeutic interventions such as dexmedetomidine and PPAR-Ī³ agonists. Wang’s work spans across multiple facets of brain injury and repair, emphasizing the roles of microglia, astrocytes, and clearance systems in these pathological processes. His contributions highlight the intricate signaling pathways and potential therapeutic targets šŸ§ šŸ”¬, advancing understanding and treatment strategies for severe neurological conditions.

Publication Top Notes

Dexmedetomidine mitigates neuroinflammation in an Alzheimer’s disease mouse model via the miR-204-3p/FBXL7 signaling axis

Published in Brain Research (2024)
Year of Publication: 2024 šŸ§ 
Neuroprotection by Nrf2 via modulating microglial phenotype and phagocytosis after intracerebral hemorrhage

Published in Heliyon (2023)
Year of Publication: 2023 šŸ§ 
Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders

Published in Neurobiology of Disease (2023)
Year of Publication: 2023 šŸ§ 
Clearance Systems in the Brain, From Structure to Function

Published in Frontiers in Cellular Neuroscience (2022)
Year of Publication: 2022 šŸ§ 
Editorial: Brain injury and repair following cerebrovascular diseases: From bench to bedside

Published in Frontiers in Cellular Neuroscience (2022)
Year of Publication: 2022 šŸ§ 

Gaiqing Wang | Neurodegeneration Disease | Research and Development Excellence Award

You May Also Like